Company intelligence / Profile preview
OncoRx Pharmaceuticals
San Diego, California, United Statesoncorxpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OncoRx Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing targeted therapies for central nervous system (CNS) cancers, including glioblastoma multiforme and brain metastases. The company's approach leverages proprietary nanoparticle formulations to improve the delivery of potent anti-cancer agents across the blood-brain barrier. Its lead candidate, ORX-301, is a nanoparticle-based microtubule inhibitor designed to enhance efficacy while minimizing systemic toxicity in patients with aggressive brain tumors. Headquartered in San Diego, OncoRx aims to address the significant unmet medical need in neuro-oncology through innovative drug delivery technologies.
- Therapeutic areas
- Oncology
- Modalities
- NanoparticleSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Providence Saint John's Health Center
Beyond the preview
Go deeper on OncoRx Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OncoRx Pharmaceuticals.